Have a personal or library account? Click to login
Association between SLC19A1 gene polymorphism and high dose methotrexate toxicity in childhood acute lymphoblastic leukaemia and non Hodgkin malignant lymphoma: introducing a haplotype based approach Cover

Association between SLC19A1 gene polymorphism and high dose methotrexate toxicity in childhood acute lymphoblastic leukaemia and non Hodgkin malignant lymphoma: introducing a haplotype based approach

Radiology and Oncology
Volume 51 (2017): Issue 4 (December 2017)
By: Barbara Faganel Kotnik,  Janez Jazbec,  Petra Bohanec Grabar,  Cristina Rodriguez-Antona and  Vita Dolzan  
Open Access
|Sep 2017

Additional Files

Supplementary Material 1

Supplementary Material 2

Supplementary Material 3

DOI: https://doi.org/10.1515/raon-2017-0040 | Journal eISSN: 1581-3207 | Journal ISSN: 1318-2099
Journal RSS Feed
Language: English
Page range: 455 - 462
Submitted on: Feb 14, 2017
|
Accepted on: Aug 18, 2017
|
Published on: Sep 18, 2017
Published by: Association of Radiology and Oncology
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Keywords:
acute lymphoblastic leukaemia,
genetic polymorphism,
haplotype,
methotrexate
Related subjects:
Medicine,
Clinical medicine,
Internal medicine,
Haematology, oncology,
Radiology

© 2017 Barbara Faganel Kotnik, Janez Jazbec, Petra Bohanec Grabar, Cristina Rodriguez-Antona, Vita Dolzan, published by Association of Radiology and Oncology
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.

Previous articleVolume 51 (2017): Issue 4 (December 2017)Next article